INTERPRETATION OF CARDIAC TROPONINS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND SUSPECTED ACUTE CORONARY SYNDROME IN THE EMERGENCY SETTING

INTERPRETATION OF CARDIAC TROPONINS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND SUSPECTED ACUTE CORONARY SYNDROME IN THE EMERGENCY SETTING

This summary provides a detailed discussion of the interpretation of elevated values in patients with chronic kidney disease and acute coronary syndrome for this EMCREG-International newsletter. It is our hope that the readers of this newsletter will find their evaluation of patients with chronic kidney disease and acute coronary syndrome more effective, resulting in improved patient care.

Read More

THE FUTURE OF CARDIAC BIOMARKERS

THE FUTURE OF CARDIAC BIOMARKERS

In this EMCREG-International newsletter, Judd E. Hollander, MD, from the Hospital of the University of Pennsylvania, discusses the development and current emergency department use of cardiac necrosis biomarkers (CK-MB, troponin, myoglobin), biomarkers of inflammation (C-reactive protein), and newer cardiac biomarkers of myocardial ischemia (brain natriuretic peptide). It is our hope to provide emergency physicians with a better understanding of the cardiac biomarkers used in emergency practice for diagnosis of ACS.

Read More